PLoS Computational Biology (Jul 2021)

Covasim: An agent-based model of COVID-19 dynamics and interventions.

  • Cliff C Kerr,
  • Robyn M Stuart,
  • Dina Mistry,
  • Romesh G Abeysuriya,
  • Katherine Rosenfeld,
  • Gregory R Hart,
  • Rafael C Núñez,
  • Jamie A Cohen,
  • Prashanth Selvaraj,
  • Brittany Hagedorn,
  • Lauren George,
  • Michał Jastrzębski,
  • Amanda S Izzo,
  • Greer Fowler,
  • Anna Palmer,
  • Dominic Delport,
  • Nick Scott,
  • Sherrie L Kelly,
  • Caroline S Bennette,
  • Bradley G Wagner,
  • Stewart T Chang,
  • Assaf P Oron,
  • Edward A Wenger,
  • Jasmina Panovska-Griffiths,
  • Michael Famulare,
  • Daniel J Klein

DOI
https://doi.org/10.1371/journal.pcbi.1009149
Journal volume & issue
Vol. 17, no. 7
p. e1009149

Abstract

Read online

The COVID-19 pandemic has created an urgent need for models that can project epidemic trends, explore intervention scenarios, and estimate resource needs. Here we describe the methodology of Covasim (COVID-19 Agent-based Simulator), an open-source model developed to help address these questions. Covasim includes country-specific demographic information on age structure and population size; realistic transmission networks in different social layers, including households, schools, workplaces, long-term care facilities, and communities; age-specific disease outcomes; and intrahost viral dynamics, including viral-load-based transmissibility. Covasim also supports an extensive set of interventions, including non-pharmaceutical interventions, such as physical distancing and protective equipment; pharmaceutical interventions, including vaccination; and testing interventions, such as symptomatic and asymptomatic testing, isolation, contact tracing, and quarantine. These interventions can incorporate the effects of delays, loss-to-follow-up, micro-targeting, and other factors. Implemented in pure Python, Covasim has been designed with equal emphasis on performance, ease of use, and flexibility: realistic and highly customized scenarios can be run on a standard laptop in under a minute. In collaboration with local health agencies and policymakers, Covasim has already been applied to examine epidemic dynamics and inform policy decisions in more than a dozen countries in Africa, Asia-Pacific, Europe, and North America.